Involves patient’s own mononuclear cells transformed into ‘cancer-fighting’ Dendritic cells.
Dendritic cells are Immune cells that help in Immune-recognition process, absent in cancer patients.
Denvax is best given in combination with conventional treatment plan like surgery, radiation and chemotherapy.
Targets only the cancer cells without harming the healthy ones.
The disseminated cancer cells responsible for the recurrence and relapse of cancer in treated patients.
Slows the spread of cancer, prevents relapse and gives quality life to most patients.
In cancer, the immune system fails, cells of the immune system fail to recognize the cancer cells. The immune system doesn't see tumors as dangerous or foreign and doesn't mount a strong attack against them. Another reason tumors may not stimulate an immune response is that cancer cells develop ways to escape the immune system.
A dendritic cell is a special type of immune cell that boosts immune responses in our body, by showing antigens on its surface to other cells of the immune system.
Dendritic cells identify cancer cells, process them into bits, and jumpstart the immune response by bringing the cancer cells to the attention of the rest of the immune system.
The activated immune system then circulates throughout the body and destroys cancer cells.
The patient or the attendant is required to contact our office, preferably nearby the patient's location. Patient is then required to send his reports and a short video, explaining or showing his/her current clinical status. The doctor evaluates the patient's clinical condition and may or may not advise Denvax, based on Eligibility Criteria. Patients willing to take Denvax treatment are required to fill and sign Informed Consent Form. The Logistics team then works at collection of blood drawl from patient’s home. They assign a trained technical staff to travel to the patient’s location for blood collection. It takes 8 days to manufacture Denvax. Denvax is then delivered via trained technical staff to the patient's home for administration.
Alternatively, patients living near and around The Denvax Clinics, may visit the Denvax office and get the treatment at The Denvax Clinic.
Dr. Jamal A. Khan and Dr. Sharmin Yaqin are leading cancer Immunotherapists in India, who introduced the concept of customised treatment in cancer, cell-based treatments, and cancer Immunotherapy.
Dr. Sharmin Yaqin, MBBS, MD (Clinical Biochemistry), was pursuing her post- graduate when she developed interest in protein extraction, and their role in cancer behaviour..
Read MoreDr Jamal A. Khan, MBBS, MD (Medical Microbiology), was a professor in Indian university, teaching Immunology when he developed interest in the power of immune system..
Read MoreKnow about our latest advancements and how they are leaving an impact on society
Connect any of our offices to begin your Denvax Treatment